Skip to content

Clinical trials

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Spain with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Status: Unknown status Country / region: Spain Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20131
20141
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fundación Teófilo Hernando, Spain1
Gruppo Italiano Malattie EMatologiche dell'Adulto1
III. Medizinische Klinik Mannheim1
Institut Català d'Oncologia1
Kartos Therapeutics, Inc.1
PETHEMA Foundation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive6
Leukemia2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative2
Breast Neoplasms1
Breast Neoplasms, Male1
Bronchiolitis Obliterans Syndrome1
Colonic Neoplasms1
Congenital Abnormalities1
Hodgkin Disease1
Immunoblastic Lymphadenopathy1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.